ProfileGDS4718 / 216927_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 42% 42% 43% 40% 42% 43% 49% 47% 44% 40% 40% 38% 38% 44% 40% 42% 38% 40% 43% 44% 43% 40% 41% 44% 41% 45% 35% 40% 39% 41% 42% 46% 44% 46% 41% 41% 41% 46% 40% 43% 40% 41% 40% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1684444
GSM549102patient 115, normal, homogenized [OPG study]5.0951342
GSM549104patient 119, normal, homogenized [OPG study]5.0631442
GSM549108patient 138, normal, homogenized [OPG study]5.1832843
GSM549119patient 077, normal, homogenized [OPG study]4.994640
GSM549133patient 032, cancer, homogenized [OPG study]5.0259742
GSM549139patient 042, cancer, homogenized [OPG study]5.1330343
GSM549099patient 107, normal, homogenized [OPG study]5.4557749
GSM549109patient 139, normal, homogenized [OPG study]5.3542947
GSM549110patient 046, normal, homogenized [OPG study]5.2057344
GSM549114patient 063, normal, homogenized [OPG study]4.9529840
GSM549122patient 082, normal, homogenized [OPG study]5.003940
GSM549134patient 033, cancer, homogenized [OPG study]4.8733538
GSM549136patient 036, cancer, homogenized [OPG study]4.8497738
GSM549140patient 044, cancer, homogenized [OPG study]5.1414644
GSM549111patient 047, normal, homogenized [OPG study]4.9902140
GSM549113patient 057, normal, homogenized [OPG study]5.0081442
GSM549132patient 031, cancer, homogenized [OPG study]4.8778138
GSM549137patient 038, cancer, homogenized [OPG study]4.9509640
GSM549142patient 047, cancer, homogenized [OPG study]5.2508643
GSM549100patient 110, normal, homogenized [OPG study]5.2266744
GSM549107patient 135, normal, homogenized [OPG study]5.1124543
GSM549115patient 068, normal, homogenized [OPG study]4.9470540
GSM549116patient 072, normal, homogenized [OPG study]5.0223341
GSM549120patient 078, normal, homogenized [OPG study]5.2020444
GSM549131patient 030, cancer, homogenized [OPG study]4.9639141
GSM549118patient 074, normal, homogenized [OPG study]5.2112145
GSM549129patient 027, cancer, homogenized [OPG study]4.7790335
GSM549123patient 088, normal, homogenized [OPG study]4.9730240
GSM549124patient 006, cancer, homogenized [OPG study]4.9801439
GSM549126patient 015, cancer, homogenized [OPG study]5.0166441
GSM549128patient 025, cancer, homogenized [OPG study]5.0498242
GSM549103patient 117, normal, homogenized [OPG study]5.3497546
GSM549117patient 073, normal, homogenized [OPG study]5.1716644
GSM549138patient 041, cancer, homogenized [OPG study]5.2589246
GSM549141patient 045, cancer, homogenized [OPG study]4.9915741
GSM549130patient 028, cancer, homogenized [OPG study]5.0600141
GSM549101patient 111, normal, homogenized [OPG study]5.0574741
GSM549105patient 128, normal, homogenized [OPG study]5.3005546
GSM549106patient 134, normal, homogenized [OPG study]4.9610940
GSM549112patient 048, normal, homogenized [OPG study]5.1377343
GSM549125patient 011, cancer, homogenized [OPG study]4.9950540
GSM549127patient 024, cancer, homogenized [OPG study]5.0343741
GSM549135patient 035, cancer, homogenized [OPG study]4.9507640